Activities of linezolid against rapidly growing mycobacteria

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 3, 2001, Pages 764-767

  Wallace R J , Jr ^a   Brown Elliott, B A ^a   Ward, S C ^a   Crist, C J ^a   Mann, L B ^a   Wilson, R W ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; OXAZOLIDINONE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM FORTUITUM; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE;

ACETAMIDES; ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; OXAZOLIDINONES; QUALITY CONTROL;

EID: 0035115570     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.3.764-767.2001     Document Type: Article

References (26)

1. Mycobacteria possess a surprisingly small number of ribosomal RNA genes in relation to the size of their genome
2. Broth microdilution MIC test for rapidly growing mycobacteria
3. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms
4. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections
5. Mycobacterium abscessus infection in cystic fibrosis
6. Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model
7. Restriction fragment length polymorphisms of 16S rRNA genes in the differentiation of fast-growing mycobacterial species
8. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials
9. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: An analysis of 154 patients
10. Nontuberculous mycobacteria: An underappreciated cause of geriatric lung disease
11. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci
12. Non-tuberculous mycobacterial pulmonary disease in cystic fibrosis
13. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae
14. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria
15. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae
16. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient
17. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis
18. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy
19. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: Importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin
20. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum
21. American Thoracic Society statement: Diagnosis and treatment of disease caused by nontuberculous mycobacteria
22. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus
23. Taxonomy of rapidly growing mycobacteria
24. Spectrum of disease due to rapidly growing mycobacteria
25. A new mycobacterial species related to Mycobacterium abscessus associated with clinical disease, pseudo-outbreaks, and contaminated metalworking fluids: Mycobacterium immunogenum sp. nov. - An international cooperative study on mycobacterial taxonomy
26. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum